Cord blood-derived human cultured mast cells produce transforming growth factor beta1

N Kanbe1, M Kurosawa, H Nagata

  • 1Department of Dermatology, Gunma University School of Medicine, Maebashi, Japan.

Abstract

Insights

Human mast cells, derived from cord blood, constitutively produce functional transforming growth factor beta1 (TGF-beta1). This finding suggests a new role for mast cells in the development of tissue fibrosis.

Area of Science:

  • Immunology
  • Cell Biology
  • Fibrosis Research

Background:

  • Mast cells are found at fibrotic sites, with suspected roles in pathogenesis.
  • The synthesis of transforming growth factor beta1 (TGF-beta1) by human mast cells remains unconfirmed.

Purpose of the Study:

  • To investigate if human mast cells from cord blood express mRNA for TGF-beta.
  • To determine if these mast cells produce bioactive TGF-beta1.

Main Methods:

  • Culturing mononuclear cells from cord blood to obtain mast cells.
  • Utilizing reverse transcriptase-polymerase chain reaction (RT-PCR) for mRNA expression analysis.
  • Performing immunocytochemical staining and bioassays to detect TGF-beta1 production.

Main Results:

  • Cultured human mast cells constitutively express TGF-beta1 mRNA.
  • Immunocytochemistry confirmed the presence of both latent and active TGF-beta forms.
  • Mast cell conditioned medium demonstrated significant TGF-beta1 bioactivity.

Conclusions:

  • Human mast cells derived from cord blood constitutively express and produce functional TGF-beta1.
  • Given TGF-beta1's fibrogenic properties, these findings indicate a novel role for mast cells in tissue fibrosis.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...